SpeechPathology.comPhone: 800-242-5183

New master brand. Same great company. Introducing continued! Read Our Story

EBS - Career of a Lifetime

Treatment of MCI: What the SLP needs to know

Treatment of MCI: What the SLP needs to know
Kim McCullough, Ph.D., CCC-SLP
March 5, 2013


This text-based course is a transcript of the event, “Treatment of MCI: What the SLP needs to know”, presented by Kimberly McCullough, Ph.D., CCC-SLP.

>> Kim McCullough:  We are going to talk about treatment of Mild Cognitive Impairment, or MCI.  Before we get started, for those of you who are new to this and do not know a lot about MCI, we are going to define it and then talk about assessment.  Then we will talk about treatment of MCI and look at some of the evidence that points in the direction we need to go for developing treatment protocols and knowing what works and what evidence supports what we might do.

MCI Defined

MCI is a transitional zone between normal cognition and dementia.  It is well documented that in most people, as we age, there are changes in cognition.  Not everyone will develop MCI, but some people certainly will.  Those people who are diagnosed with MCI do not necessarily develop dementia.  We do need to be aware that although 60% of the people who present with MCI will not develop dementia, 40% of those who have the diagnosis of MCI will.  That is certainly quite a large population to think about, because MCI does affect approximately 20% of the population over the age of 70.  We are certainly aware of the ever-increasing number of baby boomers and the explosion of the population of individuals over the age of 70.  This will be quite a substantial clinical group that we will need to be aware of.

How do we define MCI?  In 2011, there was a working group that got together with individuals from the National Institute on Aging as well as from the Alzheimer's Association, and based on all of their clinical data, they came up with the new and revised definition.  This definition states that for the person to be diagnosed with MCI, the individual has to report a concern regarding some type of change in cognition.  That concern can be raised by the patients themselves.  It can also, according to the definition, be reported by someone who knows the patient well or even by an examining clinician that is looking at their cognitive functioning.  There has to be this concern regarding the change. 

The next characteristic or feature of the diagnosis includes impairment in one or more cognitive domains.  The key to this is that you have to have some type of impairment in either memory, language, executive functioning, or visual spatial skills, and you have to score anywhere from 1 to 1.5 standard deviations below the mean.  We will look at some examples as we go through this presentation about what some of those different numbers might look like.  That is not a lot of deviation from the mean.  Sometimes it is very difficult to determine whether or not someone has mild cognitive impairment, or whether or not you are seeing normal aging.  Certainly, clinical skill comes into play here.  They are going to have a concern, they are going to have an impairment in one or more of these cognitive domains, but they are also going to be independent in all functional abilities, and they do not have dementia.  This population of individuals may still be people who work, who are very actively involved in either work or their community and have not seen a change that is great enough to cause them to not participate in activities, but enough of a change that they do have some awareness or concern.

When we look at the different types of clinical presentations in regards to MCI, there are several different types that you need to be aware of.  The first is MCI of the single domain.  Typically you will see it with memory impairments and in combination with the “MCI amnestic,” which would indicate just memory impairments.  Then you will have individuals who have MCI in multiple domains, including language, executive functioning, and visual spatial skills.  Then there will be a subcategory of patients who do not have memory impairments, but present with impairments in the other areas including language, executive functioning, and visual spatial skills. 

There are many possible etiologies associated with MCI.  Certainly it could be degenerative in nature, and these include Alzheimer's dementia, which is the most commonly occurring disease process.  In addition to that, you have Lewy Body disease, Parkinson's disease, frontotemporal dementia, and also vascular types of impairments.  You have cerebrovascular disease that can also result in dementia, and other metabolic, traumatic, and psychiatric types of disorders that may cause concern for or may present as cognitive impairments.

Below is a flowchart that is commonly seen in presentations because it is so helpful in trying to determine what types of patterns of impairment your patient is presenting with.  Basically, this flowchart restates what was discussed previously and gives you some information about how to make decisions regarding what type of impairment your patient is presenting. 

kim mccullough

Kim McCullough, Ph.D., CCC-SLP

Kim McCullough, Ph.D., CCC-SLP is an Associate Professor in the Department of Communication Sciences and Disorders at the University of Central Arkansas. She has 17 years experience as a clinician, teacher, and researcher. She teaches courses on aphasia, cognitive-communication disorders, and the neuroscience of communication. Her current research interests include developing clinically efficient assessment and treatment protocols for individuals with cognitive impairments.  

Related Courses

Optimizing Cognition: Neuroprotective practices you need to know
Presented by Kim McCullough, PhD, CCC-SLP


Kim McCullough, PhD, CCC-SLP
Course: #7600 1 Hour
  'It backed up knowledge that I already have about the topic and helped give new information that may be helpful for me to use with my patients and family in the future'   Read Reviews
Compelling evidence now exists regarding how lifestyle can optimize cognitive functioning. This course focuses on the most current research on neuroprotective lifestyle practices that enhance cognition. This course is open captioned.
Clinical Uses of the Cognitive Linguistic Quick Test
Presented by Nancy Helm-Estabrooks, Sc.D, CCC-SLP


Nancy Helm-Estabrooks, Sc.D, CCC-SLP
Course: #332 1 Hour
  'Valuable info about how to use test with different pops'   Read Reviews
During this one-hour on-line course, Dr. Nancy Helm-Estabrooks will discuss clinical uses of the Cognitive Linguistic Quick Test (CLQT). The lecture will be divided into two major areas for discussion of CLQT applications: the CLQT as an assessment/diagnostic instrument, and the CLQT as a tool for forming treatment decisions. Among the clinical populations addressed will be those with right and left hemisphere strokes, traumatic brain injury, Alzheimer's and Parkinson's disease, and mild cognitive impairment. Both research and clinical evidence that support the utility of the CLQT will be reviewed.
Treatment of Adult Acquired Apraxia of Speech: Principles & Technology
Presented by Darlene S. Williamson, M.A., CCC-SLP


Darlene S. Williamson, M.A., CCC-SLP
Course: #6201 1 Hour
  'Presentation was wel organized'   Read Reviews
This course will briefly review the salient features of acquired apraxia of speech and the principles of motor learning as they apply to best practice. Treatment approaches will be reviewed with current research findings applied to efficacy. The VAST (Video Assisted Speech Technology) approach will be demonstrated as a therapeutic and a compensatory technique.
Documenting to Demonstrate Skilled Service and Focus on Function
Presented by Nancy B. Swigert, MA, CCC-SLP, BCS-S


Nancy B. Swigert, MA, CCC-SLP, BCS-S
Course: #6227 1 Hour
  'Very good information, although dated now, I believe is still relevant in today's speech language pathology work environment'   Read Reviews
In this changing health care environment, the SLP should work closely with the patient in establishing goals that focus on function and aim to achieve the desired, measurable outcome. Medicare guidelines stipulate that services must be provided at a level of complexity requiring the services of a speech-language pathologist. Even when Medicare guidelines are followed in the provision of services, the documentation sometimes does not demonstrate the focus on function or that a skilled service was provided. This course will address how to write measurable, functional goals and provide tips on how to accurately document skilled services.
HIPAA: Defining Privacy Issues in Speech-Language Pathology
Presented by K. Todd Houston, PhD, CCC-SLP, LSLS, Cert AVT


K. Todd Houston, PhD, CCC-SLP, LSLS, Cert AVT
Course: #1033538 1 Hour
  'Great info shared throughly!'   Read Reviews
This course will address the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and its application within Speech-Language Pathology. Topics addressed will include who and what is covered by HIPAA, administrative safeguards, penalties for non-compliance, and how HIPAA relates to other laws, such as the Health Information Technology for Economic and Clinical Health (HI-TECH) Act. US rules, regulations and laws form the foundation of this course.